Kinnos a startup reimagining the way hospitals disinfect their surfaces by colorizing the process recently raised $15 million in financing. Through better sanitization practices, the company is seeking to decrease hospital-acquired infections, which cause 72,000 deaths every year.
Sanofi is acquiring rights to a Maze Therapeutics drug candidate for Pompe disease that could give the pharmaceutical giant another option to offer patients who have the rare metabolic disorder. In February, the drug posted positive data from a Phase 1 study.
Healthcare investment firm Patient Square Capital launched a new portfolio company: Elevage Medical Technologies. The company will support growth-stage medical device companies by providing capital, as well as operational and clinical expertise it received an initial investment of $300 million from Patient Square.
New CVS Health data found that while 42% of respondents are concerned about their mental health, only 12% are seeing a mental health professional, such as a psychiatrist, psychologist, psychotherapist or wellbeing therapist. Younger respondents are especially struggling: 60% of those aged 18 to 32 years old are concerned about their mental health.
The burnout crisis among nurses has gotten significantly worse since the peak of the pandemic in 2021, according to new research from AMN Healthcare. Only 40% of nurses said that they have no plans to change their work status in the coming year, and only one-third said they have ideal time to spend with their patients marking a decrease of 10 percentage points from 2021.